Medtronic Discontinues The Sof-sensor CGM Sensor


Medtronic has announced that it will no longer sell its CGM Sof-sensor as of Dec. 1, 2015. Medtronic is offering no out of pocket cost conversion programs to their latest insulin pump and CGM technology, the MiniMed 530G with Enlite. Read more

FDA Approval for Tresiba and Ryzodeg, Long Lasting Insulin Drugs

Novo_Nordisk large

More than two years after dealing Novo Nordisk a surprising setback, the U.S. Food and Drug Administration has approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve blood sugar control in adults with diabetes mellitus. … Read more

Half of US adults have diabetes or pre-diabetes, study says

Half of US adults have diabetes or pre-diabetes

New research suggests that half of all U.S. adults have diabetes or pre-diabetes.

The study of government health surveys echoes previous research and shows numbers increased substantially between 1988 and 2012 although they mostly leveled off after 2008. Overall, 12 percent to 14 percent of adults had diagnosed diabetes in 2012, the latest data available. Most of that is Type 2 diabetes, the kind linked with obesity and inactivity. Read more

FDA Approves Tandem’s t:slim G4 Insulin Pump with CGM

Tandem's t:slim G4 insulin pump with CGM

The U.S. FDA has approved Tandem’s t:slim G4 insulin pump. The t:slim G4 combines features of the t:slim Insulin Pump and Dexcom’s G4 PLATINUM CGM System into a single device that is simple to use. The t:slim G4 insulin pump is the only pump that conveniently displays CGM graphs and trend information with current insulin delivery activity together on the home screen to help make informed treatment decisions. Orders for the t:slim G4 Insulin Pump can be placed now with shipments expected to begin in October 2015. Read more

Insulet Issues Recall of OmniPod Insulin Management System

Insulet Issues Recall of OmniPod Insulin Management System

Insulet Corporation (Insulet or the Company) has initiated a lot-specific voluntary recall of 40,846 boxes (10 Pods per box) of the OmniPod (Pod) Insulin Management System. This field corrective action is due to the possibility that some of the Pods … Read more

Subscribe to our Newsletter

Hide me